McDade said this study has the longest-running data for any patients who started amyloid-lowering biologics while they were still free of symptoms. “We think that there’s a delay in the ...

For more than three decades, scientists have been racing to stop Alzheimer's disease by removing amyloid beta plaques—sticky clumps of toxic protein that accumulate in the brain. The findings ...

Gantenerumab helps eliminate one of the neurological hallmarks of Alzheimer’s, called amyloid plaques. For some participants, gantenerumab reduced their risk of developing the disease by more ...

The amyloid-β precursor protein (APP) helps to form links between the brain’s neurons. It has been highly studied because its breakdown creates amyloid-β peptides, which are often present in ...

(CNN) — For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from the brains of people destined to develop Alzheimer’s ...